Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
We aimed to compare efficacy and safety of combination therapy with oral ofloxacin, 400 mg twice daily, plus oral metronidazole, 500 mg twice daily, for 14 days, with moxifloxacin monotherapy, 400 mg once daily, for 14 days
Epistemonikos ID: fe1a037b0517de91f4e6f68960f9349b7ca3f90a
First added on: May 11, 2024